ConductScience.org, home

Paper35040751

In silico prediction of post-translational modifications in therapeutic antibodies.

Vatsa S. MAbs, 2022. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. In silico prediction of post-translational modifications in therapeutic antibodies. Papers, record 35040751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35040751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In silico prediction of post-translational modifications in therapeutic antibodies.
PubMed
Journal
MAbs
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Video-Audio Media
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
3.33
iCite
Revised in PubMed
2022-03-29
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vatsa SShabditahttps://orcid.org/0000-0003-1467-843X

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
Computer SimulationMajor topic
Protein Processing, Post-TranslationalMajor topic
Humans

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115600366Oxidation of methionine residues in aqueous solutions: free methionine and methionine in granulocyte colony-stimulating factor.J Am Chem Soc2004https://conductscience.org/library/papers/15600366PubMed
224678666A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states.Curr Protein Pept Sci2014https://conductscience.org/library/papers/24678666PubMed
326963563Length-independent structural similarities enrich the antibody CDR canonical class model.MAbs2016https://conductscience.org/library/papers/26963563PubMed
421287557Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody.J Pharm Sci2011https://conductscience.org/library/papers/21287557PubMed
523136850Role of surface exposed tryptophan as substrate generators for the antibody catalyzed water oxidation pathway.Mol Pharm2013https://conductscience.org/library/papers/23136850PubMed
621035459A new clustering of antibody CDR loop conformations.J Mol Biol2011https://conductscience.org/library/papers/21035459PubMed
730118239Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection Process.Mol Pharm2018https://conductscience.org/library/papers/30118239PubMed
828035628Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.Pharm Res2017https://conductscience.org/library/papers/28035628PubMed
929325924Prediction of the Hydrogen Peroxide-Induced Methionine Oxidation Propensity in Monoclonal Antibodies.J Pharm Sci2018https://conductscience.org/library/papers/29325924PubMed
1019009595Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form.J Pharm Sci2009https://conductscience.org/library/papers/19009595PubMed
1132189312Antigen-Antibody Complexes.Subcell Biochem2020https://conductscience.org/library/papers/32189312PubMed
1230653944High-throughput Carbonyl Content Method of Therapeutic mAb using size-exclusion chromatography with ultraviolet and fluorescence detection.Anal Biochem2019https://conductscience.org/library/papers/30653944PubMed
1325820189Improving Trastuzumab's Stability Profile by Removing the Two Degradation Hotspots.J Pharm Sci2015https://conductscience.org/library/papers/25820189PubMed
1411270864Identification of multiple sources of charge heterogeneity in a recombinant antibody.J Chromatogr B Biomed Sci Appl2001https://conductscience.org/library/papers/11270864PubMed
1516159134Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies.Anal Chem2005https://conductscience.org/library/papers/16159134PubMed
1620022755How antibodies fold.Trends Biochem Sci2010https://conductscience.org/library/papers/20022755PubMed
1732432964Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAb.MAbs2020https://conductscience.org/library/papers/32432964PubMed
1828439623Identification of multiple sources of the acidic charge variants in an IgG1 monoclonal antibody.Appl Microbiol Biotechnol2017https://conductscience.org/library/papers/28439623PubMed
1922083792Forced degradation of therapeutic proteins.J Pharm Sci2012https://conductscience.org/library/papers/22083792PubMed
2024731230Characterization of oxidative carbonylation on recombinant monoclonal antibodies.Anal Chem2014https://conductscience.org/library/papers/24731230PubMed

See all 123 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42688671Pre-Clinical and Clinical Therapies for Traumatic Brain Injury: Where Do We Stand in Pediatrics?Neurotrauma Rep2026https://conductscience.org/library/papers/42688671PubMed
42584574A Combined Experimental-Theoretical Approach Unveils the Comprehensive Asn Deamidation Kinetics.J Am Chem Soc2026https://conductscience.org/library/papers/42584574PubMed
42482306Glycosylation penetrance of N-X-S/T sequons in antibody variable domains: a structural survey of 19,265 human antibody structures reassessing the histidine/glutamine suppression hypothesis.MAbs2026https://conductscience.org/library/papers/42482306PubMed
42183827Spontaneous Non-Catalyzed Molecular Reactions and Interactions in the Human Body: Biomedical Implications.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42183827PubMed
41874027Developability Evaluation of Single-Domain Antibody-Chelator Conjugates for Diagnostic Radiotracers.Antibodies (Basel)2026https://conductscience.org/library/papers/41874027PubMed
41685150Harnessing deep learning to accelerate the development of antibodies and aptamers.Acta Pharm Sin B2026https://conductscience.org/library/papers/41685150PubMed
41246335Breaking the bind: PfEMP1-specific antibodies in cerebral malaria.Front Immunol2025https://conductscience.org/library/papers/41246335PubMed
40971455Mechanism-Driven Features Enable Asn Deamidation Reactivity Prediction via Machine Learning Methods.J Chem Inf Model2025https://conductscience.org/library/papers/40971455PubMed
40872592Exploring Experimental and In Silico Approaches for Antibody-Drug Conjugates in Oncology Therapies.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872592PubMed
39460949Addressing the antibody germline bias and its effect on language models for improved antibody design.Bioinformatics2024https://conductscience.org/library/papers/39460949PubMed
39311379The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning.Antibodies (Basel)2024https://conductscience.org/library/papers/39311379PubMed
38937372Stability of Protein Pharmaceuticals: Recent Advances.Pharm Res2024https://conductscience.org/library/papers/38937372PubMed
38927021Sequence-Based Viscosity Prediction for Rapid Antibody Engineering.Biomolecules2024https://conductscience.org/library/papers/38927021PubMed
38345400Unraveling the Microscopic Mechanism of Molecular Ion Interaction with Monoclonal Antibodies: Impact on Protein Aggregation.Mol Pharm2024https://conductscience.org/library/papers/38345400PubMed
37903302Molecular Modeling of the Deamidation Reaction in Solution: A Theoretical-Computational Study.J Phys Chem B2023https://conductscience.org/library/papers/37903302PubMed
37698932Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies.MAbs2023https://conductscience.org/library/papers/37698932PubMed
37609373How can we discover developable antibody-based biotherapeutics?Front Mol Biosci2023https://conductscience.org/library/papers/37609373PubMed
37463925KA-Search, a method for rapid and exhaustive sequence identity search of known antibodies.Sci Rep2023https://conductscience.org/library/papers/37463925PubMed
37405660SUMO: In Silico Sequence Assessment Using Multiple Optimization Parameters.Methods Mol Biol2023https://conductscience.org/library/papers/37405660PubMed
36880643Blueprint for antibody biologics developability.MAbs2023https://conductscience.org/library/papers/36880643PubMed

See all 25 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SLTM79811PubTator's text mininghttps://conductscience.org/library/genes/79811

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35040751

GET https://conductscience.org/api/papers/v1/35040751/references?page=2